N/A
N=127
Effect of Oxygen-supply on 6-Minute-Walking-Distance of COPD III/IV-patients
Chronic Obstructive Pulmonary Disease
Bottom Line
View on ClinicalTrials.gov: NCT00886639 ↗Enrolled (actual)
127
Serious AEs
—
Results posted
Jul 2011
Primary outcome: Primary: Oxygen Response — 26.9 Meter
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- 6MWT with oxygen (Other); 6MWT with medical air (Other)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- Schön Klinik Berchtesgadener Land
- Primary completion
- Jun 2009
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Oxygen Response |
26.9 | — |
| SECONDARY Oxygen Partial Pressure (paO2) |
— | — |
| SECONDARY Diffusion Capacity |
— | — |
| SECONDARY Lung Function |
— | — |
| SECONDARY BORG-Score |
— | — |
| SECONDARY Oxygen Saturation |
— | — |
| SECONDARY Oxygen Partial Pressure (paO2) |
— | — |
| SECONDARY BORG-Score |
— | — |
| SECONDARY BORG-Score |
— | — |
| SECONDARY BORG-Score |
— | — |
| SECONDARY Oxygen Partial Pressure (paO2) |
— | — |
| SECONDARY Oxygen Partial Pressure (paO2) |
— | — |
| SECONDARY Oxygen Saturation |
— | — |
| SECONDARY Oxygen Saturation |
— | — |
| SECONDARY Oxygen Saturation |
— | — |
Summary
The aim of this study is to investigate the six-minute-walking-distance of COPD-patients with breathing oxygen in comparison to breathing normal air. Patients, who increase their walking-distance about more than 15% or 35m only because of breathing oxygen, are so-called "Oxygen Responders." The study is aimed to find attributes of Oxygen Responder and to investigate, if a patient can change the "respond" with higher performance and endurance.
Eligibility Criteria
Inclusion Criteria
- Chronic obstructive pulmonary disease III/IV
Exclusion Criteria
- Severe exacerbations in the last 4 weeks prior to begin of study (definition of exacerbation: symptoms on more than 3 days with a relevant change in drug therapy (cortisone, antibiotics))
- Severe exacerbation during rehabilitation
- Cardiac insufficiency
Data sourced from ClinicalTrials.gov (NCT00886639). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.